P-572 A spanish multicentric phase II study of gemcitabine — irinotecan in relapsing or refractory small cell lung cancer (SCLC)

Authors :: Francisco Lobo
Jesus Andrade
José Luis González Larriba
Ramón García Gómez
Dolores Isla
Mariano Provencio
Laura G. Estévez
Sefa Terrasa
Manuel Domine
I. Maestu
Source :: Lung Cancer. 41:S236
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Pulmonary and Respiratory Medicine
Gemcitabine/irinotecan
Oncology
Cancer Research
medicine.medical_specialty
Refractory
business.industry
Internal medicine
Medicine
Phases of clinical research
Non small cell
business

Tools